Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lempert

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Calcified Tissue International|April 1, 1991
Inflammation-mediated osteopenia (IMO): no change in bone resorption during its developmentU G Lempert, H W Minne, H Fleisch, et al.
Bone and Mineral|November 1, 1989
Antiestrogen and antiandrogen administration reduce bone mass in the ratS Feldmann, H W Minne, S Parvizi, et al.
Acta Endocrinologica|December 1, 1992
Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cellsS Mohan, D D Strong, U G Lempert, et al.
Experimental and Clinical Endocrinology|January 1, 1994
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)S H Scharla, H W Minne, U G Lempert, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 15, 1991
[PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia]S H Scharla, M Pecherstorfer, U G Lempert, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1991
Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP)S H Scharla, H W Minne, U G Lempert, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3S H Scharla, H W Minne, S Waibel-Treber, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Calcified Tissue International|April 1, 1991
Inflammation-mediated osteopenia (IMO): no change in bone resorption during its developmentU G Lempert, H W Minne, H Fleisch, et al.
Bone and Mineral|November 1, 1989
Antiestrogen and antiandrogen administration reduce bone mass in the ratS Feldmann, H W Minne, S Parvizi, et al.
Acta Endocrinologica|December 1, 1992
Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cellsS Mohan, D D Strong, U G Lempert, et al.
Experimental and Clinical Endocrinology|January 1, 1994
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)S H Scharla, H W Minne, U G Lempert, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 15, 1991
[PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia]S H Scharla, M Pecherstorfer, U G Lempert, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1991
Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP)S H Scharla, H W Minne, U G Lempert, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3S H Scharla, H W Minne, S Waibel-Treber, et al.
Pageof 2